Hong Kong Training Portal on
Infection Control and Infectious Disease

Epidemiology and Public Health

• Epidemiology of herpes zoster and post-herpetic neuralgia in China: A nationwide population-based survey (July 30, 2025)
• A systematic literature review to assess the burden of herpes zoster disease in China (September 30, 2020)
• Risk of herpes zoster after exposure to varicella to explore the exogenous boosting hypothesis: self controlled case series study using UK electronic healthcare data (January 22, 2020) 
• The Epidemiology of Herpes Zoster in Immunocompetent, Unvaccinated Adults ≥50 Years Old: Incidence, Complications, Hospitalization, Mortality, and Recurrence (December 12, 2019)
• Herpes Zoster Risk in Immunocompromised Adults in the United States (November 02, 2019)
• The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children (November 29, 2018)
• The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014 (March 12, 2018)
• A cross-sectional study of the knowledge, attitude, and practice of patients aged 50 years or above towards herpes zoster in an out-patient setting (July 07, 2017)

Clinical Features and Management

• Epidemiology, clinical manifestations, and diagnosis of herpes zoster (last updated: February 11, 2025)
• Increase in Adult Patients with Varicella Zoster Virus–Related Central Nervous System Infections, Japan (December 2024)
• Protecting patients with SLE against herpes zoster: time for early proactive vaccine counselling (May 03, 2024)
• Varicella Zoster Virus Reactivation Following COVID-19 Vaccination: A Systematic Review of Case Reports (September 11, 2021)
• Herpes zoster infection (January 10, 2019)
• Herpes Zoster and Postherpetic Neuralgia: Prevention and Management (November 15, 2017)

Vaccination

• Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong (March 10, 2025)
• Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trial (May 03, 2024)
• Healthy ageing: Herpes zoster infection and the role of zoster vaccination (November 28, 2023)
• Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records (November 08, 2023)
• Vaccines for preventing herpes zoster in older adults (October 02, 2023)
• Public health impact of herpes zoster vaccination on older adults in Hong Kong (February 28, 2023)
• Epidemiology of Herpes Zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain (February 23, 2023)
• No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination (October 05, 2021)
• Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster (September 30, 2021)
• Herpes Zoster Vaccines (September 30, 2021)
• Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysis (January 29, 2020)
• Cost-effectiveness of the Recommendations of the Advisory Committee on Immunization Practices for the Recombinant Adjuvanted Zoster Subunit Vaccine. (July 9, 2018)
• Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older (June 27, 2018)
• Immune responses to a recombinant glycoprotein E herpes zoster vaccine in adults aged 50 years or older. (February 26, 2018)
• Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines (January 26, 2018)
• Cost-effectiveness of the Adjuvanted herpes zoster subunit vaccine in older adults. (January 02, 2018)
• Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older (September 15, 2016)